Trafalgar International, Inc. (GCAN): Total Assets
$815
As of 2025-12-31
$111
As of 2026-06-30
-85.7%
3-year compound annual growth
-66.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $815 | -98.6% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $57.8K | -66.5% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $172.3K | -38.6% | 2025-05-05, Balance as of period end |
| 2022-12-31 | $280.4K | -28.6% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $392.9K | +118.2% | 2023-04-13, Balance as of period end |
| 2020-12-31 | $180.1K | +242.0% | 2022-04-12, Balance as of period end |
| 2019-12-31 | $52.7K | -64.8% | 2021-03-26, Balance as of period end |
| 2018-12-31 | $149.6K | n/m | 2020-04-14, Balance as of period end |
| 2017-12-31 | $993 | n/a | 2018-04-26, Balance as of period end |
| 2016-12-31 | $0 | n/a | 2018-04-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Trafalgar International, Inc. (GCAN) | 2025-12-31 | $815 | -98.6% |
| CNBX Pharmaceuticals Inc. (CNBX) | 2025-08-31 | $18.4K | -41.3% |
| Nika Pharmaceuticals, Inc (NIKA) | 2025-12-31 | $21.0K | +17.1% |
| One World Products, Inc. (OWPC) | 2024-12-31 | $68.3K | -30.9% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $127.6K | -19.4% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $225.9K | -13.7% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $274.6K | +70.5% |
| Cell Source, Inc. (CLCS) | 2024-12-31 | $286.5K | +46.8% |
| ZyVersa Therapeutics, Inc. (ZVSA) | 2025-12-31 | $347.9K | -98.3% |
Compare GCAN, CNBX, NIKA, OWPC side by side · Screen every company in Pharmaceutical Preparations ↗